×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Akebia Therapeutics Inc.. (AKBA) NASDAQ

$1.54 (0.10) (-6.10%)

Market Cap: $306.27M

As of 02/28/24 04:00 PM EST. Market closed.

(AKBA)

Akebia Therapeutics Inc.. (AKBA)
NASDAQ

$1.54
(0.10) (-6.10%)

Market Cap: $306.27M

As of 02/28/24 04:00 PM EST. Market closed.

Add to Portfolio

akebia therapeutics, inc. is a biopharmaceutical company headquartered in cambridge, massachusetts, focused on delivering innovative therapies to patients with kidney disease through hypoxia-inducible factor (hif) biology. akebia’s lead product candidate, vadadustat, is an investigational oral therapy in development for the treatment of anemia related to chronic kidney disease in both ... read more

akebia therapeutics, inc. is a biopharmaceutical company headquartered in cambridge, massachusetts, focused on delivering innovative therapies to patients with kidney disease through hypoxia-inducible factor (hif) biology. akebia’s lead product candidate, vadadustat, is an investigational oral therapy in development for the treatment of anemia related to chronic kidney disease in both non-dialysis and dialysis patients. akebia’s global phase 3 program for vadadustat, which includes the pro2tect studies for non-dialysis patients with anemia associated with chronic kidney disease and the inno2vate studies for dialysis-dependent patients, is currently ongoing. for more information, please visit our website at www.akebia.com. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
John Butler
Full Time Employees
353
CEO Compensation (Base)
$594,720
CEO Compensation (Total)
$3.47M
URL
Address
245 1st St, Massachusetts, Cambridge, 02142-1200.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
John Butler
Full Time Employees
353
CEO Compensation (Base)
$594,720
CEO Compensation (Total)
$3.47M
Address
245 1st St, Massachusetts, Cambridge, 02142-1200.
PRICE CHART FOR AKEBIA THERAPEUTICS INC.
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$1.64
Days Range
$1.54 - $1.68
52 week range
$0.49 - $1.84
Volume
2,458,703
Avg. Volume (30 days)
2,095,696
Market Cap
$306.27M
Dividend Yield
-
P/E
(5.01)
Shares Outstanding
198,874,689
Open
-
Previous Close
$1.64
Days Range
$1.54 - $1.68
52 week range
$0.49 - $1.84
Volume
2,458,703
Avg. Volume (30 days)
2,095,696
Market Cap
$306.27M
Dividend Yield
-
P/E
(5.01)
Shares Outstanding
198,874,689
FINANCIAL STATEMENTS FOR AKEBIA THERAPEUTICS INC.
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR AKEBIA THERAPEUTICS INC.
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Burke Steven KeithSVP, Chief Medical OfficerFeb 01, 2024 Sale$1.6824,31140,842711,376Feb 02, 2024, 04:10 PM
Hadas Nicole R.SVP, Chief Legal OfficerMay 25, 2023 Sale$1.2263,18677,270524,344May 25, 2023, 09:01 PM
Dahan MichelSVP, Chief Operating OfficerMay 25, 2023 Sale$1.2295,478116,760574,037May 25, 2023, 09:01 PM
Burke Steven KeithSVP, Chief Medical OfficerMay 16, 2023 Sale$1.0763,56767,890530,487May 18, 2023, 06:20 PM
Spellman David ASVP, CFO and TreasurerMay 16, 2023 Sale$1.0763,56767,890446,483May 18, 2023, 06:19 PM
Butler John P.CEO and PresidentMar 01, 2023 Sale$0.8891,86880,6141,622,481Mar 03, 2023, 08:01 AM
Hadas Nicole R.SVP, Chief Legal OfficerMar 01, 2023 Sale$0.8813,03411,437295,231Mar 03, 2023, 08:01 AM
Burke Steven KeithSVP, Chief Medical OfficerMar 01, 2023 Sale$0.8814,12312,393601,564Mar 03, 2023, 08:01 AM
Dahan MichelSVP, Chief Operating OfficerMar 01, 2023 Sale$0.8820,41217,912281,869Mar 03, 2023, 08:01 AM
Spellman David ASVP, CFO and TreasurerMar 01, 2023 Sale$0.887,2106,327510,860Mar 03, 2023, 08:00 AM
Butler John P.CEO and PresidentFeb 27, 2023 Sale$0.8138,63231,4161,660,740Mar 01, 2023, 04:07 PM
Burke Steven KeithSVP, Chief Medical OfficerFeb 27, 2023 Sale$0.817,5396,131608,177Mar 01, 2023, 04:06 PM
Spellman David ASVP, CFO and TreasurerFeb 27, 2023 Sale$0.817,5396,131517,260Mar 01, 2023, 04:05 PM
Burke Steven KeithSVP, Chief Medical OfficerAug 31, 2022 Sale$0.361,147416418,016Sep 01, 2022, 04:15 PM
GILMAN STEVEN CDirectorJun 03, 2022 Sale$0.364,5671,65343,430Jun 07, 2022, 04:03 PM
Butler John P.CEO and PresidentMar 01, 2022 Sale$2.1753,973117,1591,432,409Mar 02, 2022, 09:25 PM
Butler John P.CEO and PresidentFeb 28, 2022 Sale$2.1525,05353,9841,164,095Mar 02, 2022, 09:25 PM
Burke Steven KeithSVP, Chief Medical OfficerFeb 28, 2022 Sale$2.157,40015,946163,819Mar 02, 2022, 09:12 PM
Burke Steven KeithSVP, Chief Medical OfficerMar 01, 2022 Sale$2.177,65616,619217,663Mar 02, 2022, 09:12 PM
Cotreau ViolettaSVP, Chief Accounting OfficerFeb 28, 2022 Sale$2.153,9468,50329,121Mar 02, 2022, 09:12 PM
Dahan MichelSVP, Chief Operating OfficerMar 01, 2022 Sale$2.1714,97832,513302,122Mar 02, 2022, 09:11 PM
Dahan MichelSVP, Chief Operating OfficerFeb 28, 2022 Sale$2.156,55514,125258,995Mar 02, 2022, 09:11 PM
Faulkingham DellSVP, CCOMar 01, 2022 Sale$2.176,70514,555174,798Mar 02, 2022, 09:10 PM
Faulkingham DellSVP, CCOFeb 28, 2022 Sale$2.156,47913,961130,546Mar 02, 2022, 09:10 PM
Hadas Nicole R.SVP, Chief Legal OfficerFeb 28, 2022 Sale$2.156,55514,125265,748Mar 02, 2022, 09:10 PM
Hadas Nicole R.SVP, Chief Legal OfficerMar 01, 2022 Sale$2.1714,50731,490308,875Mar 02, 2022, 09:10 PM
Spellman David ASVP, CFO and TreasurerMar 01, 2022 Sale$2.178031,743128,599Mar 02, 2022, 09:09 PM
Spellman David ASVP, CFO and TreasurerFeb 28, 2022 Sale$2.157,40015,94669,402Mar 02, 2022, 09:09 PM
Cotreau ViolettaSVP, Chief Accounting OfficerJan 03, 2022 Sale$2.295,83313,33533,067Jan 05, 2022, 04:11 PM
Burke Steven KeithSVP, Chief Medical OfficerAug 31, 2021 Sale$2.831,0422,949171,219Sep 02, 2021, 04:07 PM
Faulkingham DellSVP, CCOApr 01, 2021 Sale$3.409523,237137,025Apr 01, 2021, 08:35 PM
Spellman David ASVP, CFO and TreasurerApr 01, 2021 Sale$3.407902,68676,802Apr 01, 2021, 08:34 PM
Hadas Nicole R.SVP, Chief Legal OfficerApr 01, 2021 Sale$3.401,0603,604272,303Apr 01, 2021, 08:33 PM
Dahan MichelSVP, Chief Operating OfficerApr 01, 2021 Sale$3.401,2114,117265,550Apr 01, 2021, 08:33 PM
Butler John P.CEO and PresidentApr 01, 2021 Sale$3.404,10913,9711,152,153Apr 01, 2021, 08:32 PM
Burke Steven KeithSVP, Chief Medical OfficerApr 01, 2021 Sale$3.401,0813,675170,761Apr 01, 2021, 08:31 PM
Butler John P.CEO and PresidentMar 01, 2021 Sale$3.4049,990169,7711,141,416Mar 02, 2021, 04:10 PM
Faulkingham DellCCOMar 01, 2021 Sale$3.406,74922,920128,825Mar 02, 2021, 04:08 PM
Hadas Nicole R.SVP, Chief Legal OfficerMar 01, 2021 Sale$3.4014,28548,513271,147Mar 02, 2021, 04:08 PM
Dahan MichelSVP, Chief Operating OfficerMar 01, 2021 Sale$3.4014,54749,403263,058Mar 02, 2021, 04:08 PM
Burke Steven KeithSVP, Chief Medical OfficerMar 01, 2021 Sale$3.407,55825,668161,442Mar 02, 2021, 04:06 PM
Smith CynthiaDirectorJun 08, 2020 Sale$12.104,56755,26137,833Jun 09, 2020, 04:17 PM
GILMAN STEVEN CDirectorJun 08, 2020 Sale$12.084,56755,16938,864Jun 09, 2020, 04:17 PM
GOWEN MAXINEDirectorJun 08, 2020 Sale$12.054,56755,03224,133Jun 09, 2020, 04:17 PM
Faulkingham DellCCOJun 01, 2020 Sale$11.586,42674,41373,574Jun 02, 2020, 04:34 PM
Dahan MichelSVP, Chief Operating OfficerFeb 28, 2020 Sale$8.706,97260,656204,960Mar 02, 2020, 07:29 PM
Hadas Nicole R.SVP, Chief Legal OfficerFeb 28, 2020 Sale$8.707,05061,335212,756Mar 02, 2020, 07:28 PM
Amello JasonSVP, CFO & TreasurerFeb 28, 2020 Sale$8.706,97660,691144,642Mar 02, 2020, 07:27 PM
Tubridy Karen LSVP, Chief Development OfficerFeb 28, 2020 Sale$8.703,45430,05084,679Mar 02, 2020, 07:26 PM
GILMAN STEVEN CDirectorNov 20, 2019 Buy$3.435,80019,89429,731Nov 22, 2019, 06:20 AM
Smith CynthiaDirectorNov 20, 2019 Buy$3.5215,00052,80028,700Nov 22, 2019, 06:20 AM
Burke Steven KeithSVP, Chief Medical OfficerNov 20, 2019 Buy$3.5827,00096,66037,000Nov 22, 2019, 06:19 AM
Butler John P.CEO and PresidentNov 20, 2019 Buy$3.4450,000172,000887,732Nov 21, 2019, 06:32 AM
ADAMS ADRIANDirectorNov 20, 2019 Buy$3.4150,000170,50063,700Nov 21, 2019, 06:31 AM
Butler John P.CEO and PresidentJun 03, 2019 Option Exercise$0.47287,000134,890836,232Jun 05, 2019, 04:05 PM
Jain RitaSVP, Chief Medical OfficerApr 11, 2019 Option Exercise$7.704,40933,94996,332Apr 12, 2019, 04:01 PM
Dahan MichelSVP, Chief Business OfficerApr 11, 2019 Option Exercise$7.7011,90991,699146,932Apr 12, 2019, 04:01 PM
Hadas Nicole R.SVP, CLO & SecretaryApr 11, 2019 Option Exercise$7.7011,92991,853154,806Apr 12, 2019, 04:00 PM
Tubridy Karen LSVP, Chief Development OfficerApr 11, 2019 Option Exercise$7.706,07546,77755,324Apr 12, 2019, 04:00 PM
Amello JasonSVP, CFO & TreasurerApr 11, 2019 Option Exercise$7.7013,148101,240118,618Apr 12, 2019, 04:00 PM
Tubridy Karen LSVP, Chief Development OfficerDec 12, 2018 Option Exercise$8.9411,928106,63630,229Dec 13, 2018, 08:18 AM
Jain RitaSVP, Chief Medical OfficerDec 12, 2018 Option Exercise$8.948,65977,41120,741Dec 13, 2018, 08:17 AM
Hadas Nicole R.SVP, General Counsel, Sec.Dec 12, 2018 Option Exercise$8.9420,175180,364101,284Dec 13, 2018, 08:15 AM
Dahan MichelSVP, Chief Business OfficerDec 12, 2018 Option Exercise$8.9423,385209,06293,841Dec 13, 2018, 08:14 AM
Butler John P.CEO & PresidentDec 12, 2018 Option Exercise$8.94135,6971,213,131374,617Dec 13, 2018, 08:10 AM
Amello JasonSVP, CFO & TreasurerDec 12, 2018 Option Exercise$8.9422,235198,78166,501Dec 13, 2018, 08:08 AM
Butler John P.CEO and PresidentJul 11, 2018 Option Exercise$0.47100,00047,000510,314Jul 12, 2018, 04:59 PM
Nash DuaneDirectorFeb 15, 2018 Sale$14.621,00014,62021,499Feb 16, 2018, 04:07 PM
Nash DuaneDirectorOct 02, 2017 Sale$19.641,18823,33222,499Oct 04, 2017, 04:21 PM
Hadas Nicole R.SVP, General Counsel, Sec.Oct 02, 2017 Sale$19.897,803155,188108,054Oct 04, 2017, 04:21 PM
Dahan MichelSVP, Chief Business OfficerOct 02, 2017 Sale$19.641,39827,45795,826Oct 04, 2017, 04:20 PM
Dahan MichelSVP, Chief Business OfficerSep 28, 2017 Sale$19.305,00096,50097,224Oct 02, 2017, 04:04 PM
Dahan MichelSVP, Chief Business OfficerAug 15, 2017 Sale$15.005,00075,000102,224Aug 17, 2017, 04:06 PM
Satter Muneer ADirectorJul 05, 2017 Buy$14.501,034,48214,999,9893,037,042Jul 11, 2017, 04:14 PM
Dahan MichelSVP, Chief Business OfficerJul 03, 2017 Sale$14.261,39919,947107,224Jul 06, 2017, 12:25 PM
Hadas Nicole R.SVP, General Counsel, Sec.Jul 03, 2017 Sale$14.261,55422,156109,607Jul 06, 2017, 12:24 PM
Nash DuaneDirectorJul 03, 2017 Sale$14.2799014,12723,687Jul 06, 2017, 12:23 PM
Dahan MichelSVP, Chief Business OfficerApr 03, 2017 Sale$9.181,40112,858108,623Apr 04, 2017, 04:01 PM
Nash DuaneDirectorApr 03, 2017 Sale$9.209919,11924,677Apr 04, 2017, 04:01 PM
Hadas Nicole R.SVP, General Counsel, Sec.Apr 03, 2017 Sale$9.181,55614,280109,856Apr 04, 2017, 04:01 PM
Butler John P.CEO and PresidentJan 19, 2017 Option Exercise$0.4720,0009,400373,480Jan 23, 2017, 04:10 PM
Dahan MichelSVP, Chief Business OfficerJan 01, 2017 Sale$10.491,62917,08970,524Jan 03, 2017, 04:02 PM
Nash DuaneDirectorJan 03, 2017 Sale$10.461,98020,71125,668Jan 03, 2017, 04:02 PM
Hadas Nicole R.SVP, General Counsel, Sec.Jan 01, 2017 Sale$10.491,81018,98882,912Jan 03, 2017, 04:01 PM
Nash DuaneDirectorOct 03, 2016 Sale$8.961,98117,74627,648Oct 04, 2016, 04:12 PM
Dahan MichelSVP, Chief Business OfficerOct 01, 2016 Sale$8.951,40112,54672,153Oct 04, 2016, 04:12 PM
Hadas Nicole R.SVP, General Counsel, Sec.Oct 01, 2016 Sale$8.951,55613,93483,915Oct 04, 2016, 04:12 PM
Nash DuaneDirectorJul 06, 2016 Sale$7.481,98014,81929,629Jul 07, 2016, 04:07 PM
Dahan MichelSVP, Chief Business OfficerJul 05, 2016 Sale$7.471,40210,46873,554Jul 06, 2016, 04:08 PM
Hadas Nicole R.SVP, General Counsel, Sec.Jul 05, 2016 Sale$7.471,55711,62585,471Jul 06, 2016, 04:08 PM
Hadas Nicole R.SVP, General Counsel, Sec.Apr 04, 2016 Sale$9.411,55614,64285,528Apr 05, 2016, 04:03 PM
Dahan MichelSVP, Chief Business OfficerApr 04, 2016 Sale$9.411,40113,18374,956Apr 05, 2016, 04:01 PM
Butler John P.CEO and PresidentJan 15, 2016 Option Exercise$0.4725,00011,750225,673Jan 19, 2016, 04:00 PM
Hadas Nicole R.SVP, General Counsel, Sec.Jan 04, 2016 Sale$12.281,81122,23964,584Jan 06, 2016, 04:04 PM
Nash DuaneDirectorOct 02, 2015 Sale$8.659968,61731,609Oct 05, 2015, 04:06 PM
Hadas Nicole R.SVP, General Counsel, Sec.Oct 02, 2015 Sale$8.671,48412,86065,260Oct 05, 2015, 04:02 PM
Nash DuaneDirectorJul 02, 2015 Sale$9.539969,49032,605Jul 06, 2015, 04:04 PM
Hadas Nicole R.SVP, General Counsel, Sec.Jul 02, 2015 Sale$9.541,48414,16066,744Jul 06, 2015, 04:03 PM
Hadas Nicole R.SVP, General Counsel, Sec.Apr 02, 2015 Sale$9.091,48313,47867,015Jul 02, 2015, 07:29 AM
Hadas Nicole R.SVP, General Counsel, Sec.Jan 02, 2015 Sale$11.461,71519,65568,498Jul 02, 2015, 07:27 AM
Nash DuaneDirectorApr 01, 2015 Option Exercise$9.511,98018,83013,012Jun 09, 2015, 04:19 PM
Nash DuaneDirectorApr 02, 2015 Sale$9.099969,05212,016Jun 09, 2015, 04:19 PM
Nash DuaneDirectorJan 01, 2015 Option Exercise$11.641,98023,04713,809Jun 09, 2015, 04:13 PM
Nash DuaneDirectorJan 02, 2015 Sale$11.4699511,40312,814Jun 09, 2015, 04:13 PM
Nash DuaneDirectorDec 23, 2014 Option Exercise$11.5423,762274,21323,762Jun 09, 2015, 04:07 PM
Nash DuaneDirectorDec 26, 2014 Sale$11.195,16957,84611,829Jun 09, 2015, 04:07 PM
Nash DuaneDirectorDec 24, 2014 Sale$11.266,76476,18916,998Jun 09, 2015, 04:07 PM
Butler John P.CEO and PresidentMay 26, 2015 Option Exercise$0.4750,00023,500198,350May 28, 2015, 06:31 AM
Satter Muneer ADirectorApr 22, 2015 Buy$8.25420,0003,465,0002,002,560Apr 22, 2015, 04:25 PM
Nash DuaneDirectorApr 01, 2015 Option Exercise$9.511,98018,83013,012Apr 06, 2015, 04:14 PM
Nash DuaneDirectorApr 02, 2015 Sale$9.099969,05212,016Apr 06, 2015, 04:14 PM
Hadas Nicole R.SVP, General Counsel, Sec.Apr 01, 2015 Option Exercise$9.514,53943,16677,576Apr 06, 2015, 04:13 PM
Hadas Nicole R.SVP, General Counsel, Sec.Apr 02, 2015 Sale$9.091,48313,47876,093Apr 06, 2015, 04:13 PM
Butler John P.CEO and PresidentMar 09, 2015 Option Exercise$0.47100,00047,000148,350Mar 11, 2015, 06:23 AM
Hadas Nicole R.VP General Counsel & SecretaryJan 01, 2015 Option Exercise$11.644,53952,83474,752Jan 05, 2015, 04:35 PM
Hadas Nicole R.VP General Counsel & SecretaryJan 02, 2015 Sale$11.461,71519,65573,037Jan 05, 2015, 04:35 PM
Nash DuaneDirectorJan 01, 2015 Option Exercise$11.641,98023,04713,809Jan 05, 2015, 04:32 PM
Nash DuaneDirectorJan 02, 2015 Sale$11.4699511,40312,814Jan 05, 2015, 04:32 PM
Nash DuaneDirectorDec 23, 2014 Option Exercise$11.5423,762274,21323,762Jan 05, 2015, 04:30 PM
Nash DuaneDirectorDec 24, 2014 Sale$11.266,76476,18916,998Jan 05, 2015, 04:30 PM
Nash DuaneDirectorDec 26, 2014 Sale$11.195,16957,84611,829Jan 05, 2015, 04:30 PM
Butler John P.CEO and PresidentDec 29, 2014 Buy$11.571,00011,56748,350Dec 29, 2014, 05:16 PM
Nash DuaneDirectorDec 23, 2014 Option Exercise$11.5423,762274,21323,762Dec 29, 2014, 04:25 PM
Nash DuaneDirectorDec 26, 2014 Sale$11.195,16957,84611,829Dec 29, 2014, 04:25 PM
Nash DuaneDirectorDec 24, 2014 Sale$11.266,76476,18916,998Dec 29, 2014, 04:25 PM
Butler John P.CEO and PresidentDec 22, 2014 Buy$11.921,00011,91647,350Dec 22, 2014, 04:11 PM
Butler John P.CEO and PresidentDec 15, 2014 Buy$11.341,00011,33646,350Dec 18, 2014, 04:02 PM
Hadas Nicole R.VP General Counsel & SecretaryDec 02, 2014 Option Exercise$11.435,91067,55170,213Dec 03, 2014, 04:07 PM
Renaud Ronald C JRDirectorDec 02, 2014 Buy$11.925,00059,5875,000Dec 02, 2014, 06:42 PM
Amello JasonSVP, CFO & TreasurerNov 26, 2014 Buy$13.221,00013,2205,000Dec 01, 2014, 06:13 AM
Satter Muneer ADirectorNov 25, 2014 Buy$13.185,00065,9001,582,560Nov 26, 2014, 07:26 AM
Satter Muneer ADirectorNov 24, 2014 Buy$13.885,00069,4001,577,560Nov 25, 2014, 06:02 AM
Satter Muneer ADirectorNov 21, 2014 Buy$14.735,00073,6501,572,560Nov 24, 2014, 06:50 AM
Satter Muneer ADirectorNov 20, 2014 Buy$14.705,00073,5001,567,560Nov 21, 2014, 07:40 AM
Satter Muneer ADirectorNov 19, 2014 Buy$14.855,00074,2501,562,560Nov 20, 2014, 06:13 AM
Satter Muneer ADirectorNov 18, 2014 Buy$13.845,00069,2001,557,560Nov 19, 2014, 06:04 AM
Satter Muneer ADirectorNov 17, 2014 Buy$12.945,00064,7001,552,560Nov 18, 2014, 07:18 AM
Satter Muneer ADirectorNov 13, 2014 Buy$11.565,00057,8001,542,560Nov 14, 2014, 07:31 AM
GOWEN MAXINEDirectorNov 13, 2014 Buy$11.821,30015,3651,300Nov 14, 2014, 06:55 AM
Butler John P.CEO and PresidentNov 11, 2014 Option Exercise$0.4730,50014,33544,350Nov 13, 2014, 06:21 AM
Butler John P.CEO and PresidentNov 12, 2014 Buy$10.311,00010,30545,350Nov 13, 2014, 06:21 AM
Satter Muneer ADirectorNov 12, 2014 Buy$11.905,00059,5151,537,560Nov 13, 2014, 06:20 AM
Novartis Bioventures Ltd10% OwnerMar 25, 2014 Buy$17.00182,5903,104,030182,590Mar 27, 2014, 04:02 PM
WYZGA MICHAEL SDirectorMar 25, 2014 Buy$17.001,50025,5001,500Mar 27, 2014, 04:01 PM
Hadas Nicole R.See RemarksMar 25, 2014 Buy$17.003,50059,50076,123Mar 27, 2014, 04:00 PM
Satter Muneer ADirectorMar 25, 2014 Buy$17.0091,2951,552,0151,532,560Mar 27, 2014, 04:00 PM
Butler John P.President and CEOMar 25, 2014 Buy$17.0013,850235,45013,850Mar 27, 2014, 04:00 PM
Amello JasonSVP, CFO & TreasurerMar 25, 2014 Buy$17.004,00068,0004,000Mar 27, 2014, 04:00 PM
Novo A/S10% OwnerMar 25, 2014 Buy$17.00182,5903,104,0301,516,387Mar 26, 2014, 05:44 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Burke Steven KeithSVP, Chief Medical Officer02/01/202440,842
Hadas Nicole R.SVP, Chief Legal Officer05/25/202377,270
Dahan MichelSVP, Chief Operating Officer05/25/2023116,760
Burke Steven KeithSVP, Chief Medical Officer05/16/202367,890
Spellman David ASVP, CFO and Treasurer05/16/202367,890
Butler John P.CEO and President03/01/202380,614
Hadas Nicole R.SVP, Chief Legal Officer03/01/202311,437
Burke Steven KeithSVP, Chief Medical Officer03/01/202312,393
Dahan MichelSVP, Chief Operating Officer03/01/202317,912
Spellman David ASVP, CFO and Treasurer03/01/20236,327
Butler John P.CEO and President02/27/202331,416
Burke Steven KeithSVP, Chief Medical Officer02/27/20236,131
Spellman David ASVP, CFO and Treasurer02/27/20236,131
Burke Steven KeithSVP, Chief Medical Officer08/31/2022416
GILMAN STEVEN CDirector06/03/20221,653
Butler John P.CEO and President03/01/2022117,159
Butler John P.CEO and President02/28/202253,984
Burke Steven KeithSVP, Chief Medical Officer02/28/202215,946
Burke Steven KeithSVP, Chief Medical Officer03/01/202216,619
Cotreau ViolettaSVP, Chief Accounting Officer02/28/20228,503
Dahan MichelSVP, Chief Operating Officer03/01/202232,513
Dahan MichelSVP, Chief Operating Officer02/28/202214,125
Faulkingham DellSVP, CCO03/01/202214,555
Faulkingham DellSVP, CCO02/28/202213,961
Hadas Nicole R.SVP, Chief Legal Officer02/28/202214,125
Hadas Nicole R.SVP, Chief Legal Officer03/01/202231,490
Spellman David ASVP, CFO and Treasurer03/01/20221,743
Spellman David ASVP, CFO and Treasurer02/28/202215,946
Cotreau ViolettaSVP, Chief Accounting Officer01/03/202213,335
Burke Steven KeithSVP, Chief Medical Officer08/31/20212,949
Faulkingham DellSVP, CCO04/01/20213,237
Spellman David ASVP, CFO and Treasurer04/01/20212,686
Hadas Nicole R.SVP, Chief Legal Officer04/01/20213,604
Dahan MichelSVP, Chief Operating Officer04/01/20214,117
Butler John P.CEO and President04/01/202113,971
Burke Steven KeithSVP, Chief Medical Officer04/01/20213,675
Butler John P.CEO and President03/01/2021169,771
Faulkingham DellCCO03/01/202122,920
Hadas Nicole R.SVP, Chief Legal Officer03/01/202148,513
Dahan MichelSVP, Chief Operating Officer03/01/202149,403
Burke Steven KeithSVP, Chief Medical Officer03/01/202125,668
Smith CynthiaDirector06/08/202055,261
GILMAN STEVEN CDirector06/08/202055,169
GOWEN MAXINEDirector06/08/202055,032
Faulkingham DellCCO06/01/202074,413
Dahan MichelSVP, Chief Operating Officer02/28/202060,656
Hadas Nicole R.SVP, Chief Legal Officer02/28/202061,335
Amello JasonSVP, CFO & Treasurer02/28/202060,691
Tubridy Karen LSVP, Chief Development Officer02/28/202030,050
GILMAN STEVEN CDirector11/20/201919,894
Smith CynthiaDirector11/20/201952,800
Burke Steven KeithSVP, Chief Medical Officer11/20/201996,660
Butler John P.CEO and President11/20/2019172,000
ADAMS ADRIANDirector11/20/2019170,500
Butler John P.CEO and President06/03/2019134,890
Jain RitaSVP, Chief Medical Officer04/11/201933,949
Dahan MichelSVP, Chief Business Officer04/11/201991,699
Hadas Nicole R.SVP, CLO & Secretary04/11/201991,853
Tubridy Karen LSVP, Chief Development Officer04/11/201946,777
Amello JasonSVP, CFO & Treasurer04/11/2019101,240
Tubridy Karen LSVP, Chief Development Officer12/12/2018106,636
Jain RitaSVP, Chief Medical Officer12/12/201877,411
Hadas Nicole R.SVP, General Counsel, Sec.12/12/2018180,364
Dahan MichelSVP, Chief Business Officer12/12/2018209,062
Butler John P.CEO & President12/12/20181,213,131
Amello JasonSVP, CFO & Treasurer12/12/2018198,781
Butler John P.CEO and President07/11/201847,000
Nash DuaneDirector02/15/201814,620
Nash DuaneDirector10/02/201723,332
Hadas Nicole R.SVP, General Counsel, Sec.10/02/2017155,188
Dahan MichelSVP, Chief Business Officer10/02/201727,457
Dahan MichelSVP, Chief Business Officer09/28/201796,500
Dahan MichelSVP, Chief Business Officer08/15/201775,000
Satter Muneer ADirector07/05/201714,999,989
Dahan MichelSVP, Chief Business Officer07/03/201719,947
Hadas Nicole R.SVP, General Counsel, Sec.07/03/201722,156
Nash DuaneDirector07/03/201714,127
Dahan MichelSVP, Chief Business Officer04/03/201712,858
Nash DuaneDirector04/03/20179,119
Hadas Nicole R.SVP, General Counsel, Sec.04/03/201714,280
Butler John P.CEO and President01/19/20179,400
Dahan MichelSVP, Chief Business Officer01/01/201717,089
Nash DuaneDirector01/03/201720,711
Hadas Nicole R.SVP, General Counsel, Sec.01/01/201718,988
Nash DuaneDirector10/03/201617,746
Dahan MichelSVP, Chief Business Officer10/01/201612,546
Hadas Nicole R.SVP, General Counsel, Sec.10/01/201613,934
Nash DuaneDirector07/06/201614,819
Dahan MichelSVP, Chief Business Officer07/05/201610,468
Hadas Nicole R.SVP, General Counsel, Sec.07/05/201611,625
Hadas Nicole R.SVP, General Counsel, Sec.04/04/201614,642
Dahan MichelSVP, Chief Business Officer04/04/201613,183
Butler John P.CEO and President01/15/201611,750
Hadas Nicole R.SVP, General Counsel, Sec.01/04/201622,239
Nash DuaneDirector10/02/20158,617
Hadas Nicole R.SVP, General Counsel, Sec.10/02/201512,860
Nash DuaneDirector07/02/20159,490
Hadas Nicole R.SVP, General Counsel, Sec.07/02/201514,160
Hadas Nicole R.SVP, General Counsel, Sec.04/02/201513,478
Hadas Nicole R.SVP, General Counsel, Sec.01/02/201519,655
Nash DuaneDirector04/01/201518,830
Nash DuaneDirector04/02/20159,052
Nash DuaneDirector01/01/201523,047
Nash DuaneDirector01/02/201511,403
Nash DuaneDirector12/23/2014274,213
Nash DuaneDirector12/26/201457,846
Nash DuaneDirector12/24/201476,189
Butler John P.CEO and President05/26/201523,500
Satter Muneer ADirector04/22/20153,465,000
Nash DuaneDirector04/01/201518,830
Nash DuaneDirector04/02/20159,052
Hadas Nicole R.SVP, General Counsel, Sec.04/01/201543,166
Hadas Nicole R.SVP, General Counsel, Sec.04/02/201513,478
Butler John P.CEO and President03/09/201547,000
Hadas Nicole R.VP General Counsel & Secretary01/01/201552,834
Hadas Nicole R.VP General Counsel & Secretary01/02/201519,655
Nash DuaneDirector01/01/201523,047
Nash DuaneDirector01/02/201511,403
Nash DuaneDirector12/23/2014274,213
Nash DuaneDirector12/24/201476,189
Nash DuaneDirector12/26/201457,846
Butler John P.CEO and President12/29/201411,567
Nash DuaneDirector12/23/2014274,213
Nash DuaneDirector12/26/201457,846
Nash DuaneDirector12/24/201476,189
Butler John P.CEO and President12/22/201411,916
Butler John P.CEO and President12/15/201411,336
Hadas Nicole R.VP General Counsel & Secretary12/02/201467,551
Renaud Ronald C JRDirector12/02/201459,587
Amello JasonSVP, CFO & Treasurer11/26/201413,220
Satter Muneer ADirector11/25/201465,900
Satter Muneer ADirector11/24/201469,400
Satter Muneer ADirector11/21/201473,650
Satter Muneer ADirector11/20/201473,500
Satter Muneer ADirector11/19/201474,250
Satter Muneer ADirector11/18/201469,200
Satter Muneer ADirector11/17/201464,700
Satter Muneer ADirector11/13/201457,800
GOWEN MAXINEDirector11/13/201415,365
Butler John P.CEO and President11/11/201414,335
Butler John P.CEO and President11/12/201410,305
Satter Muneer ADirector11/12/201459,515
Novartis Bioventures Ltd10% Owner03/25/20143,104,030
WYZGA MICHAEL SDirector03/25/201425,500
Hadas Nicole R.See Remarks03/25/201459,500
Satter Muneer ADirector03/25/20141,552,015
Butler John P.President and CEO03/25/2014235,450
Amello JasonSVP, CFO & Treasurer03/25/201468,000
Novo A/S10% Owner03/25/20143,104,030
Load More Insider Transactions
FUNDS WITH A POSITION IN AKEBIA THERAPEUTICS INC.
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RENAISSANCE TECHNOLOGIES LLC4,779,3830.00917%51.47%Other
BLACKROCK INC.3,122,8240.0001%27.27%Other
GEODE CAPITAL MANAGEMENT, LLC1,801,6900.00023%4.49%Other
TUDOR INVESTMENT CORP ET AL142,2740.00142%No changeEvent Driven, Other
CHANGE IN SHARES OUTSTANDING FOR AKEBIA THERAPEUTICS INC.
STOCK BUYBACKS FOR AKEBIA THERAPEUTICS INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
0.80%
1Q
09/30/2023
03/31/2023
1.91%
2Q
09/30/2023
12/31/2022
2.34%
3Q
09/30/2023
09/30/2022
2.41%
4Q
09/30/2023
06/30/2022
-1.09%
5Q
09/30/2023
03/31/2022
4.85%
6Q
09/30/2023
12/31/2021
7.82%
7Q
09/30/2023
09/30/2021
8.36%
8Q
09/30/2023
06/30/2021
16.72%
9Q
09/30/2023
03/31/2021
22.42%
10Q
09/30/2023
12/31/2020
29.72%
11Q
09/30/2023
09/30/2020
31.39%
12Q
09/30/2023
06/30/2020
37.54%
13Q
09/30/2023
03/31/2020
46.66%
14Q
09/30/2023
12/31/2019
57.75%
15Q
09/30/2023
09/30/2019
58.42%
16Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
0.80%
1Q
03/31/2023
1.91%
2Q
12/31/2022
2.34%
3Q
09/30/2022
2.41%
4Q
06/30/2022
-1.09%
5Q
03/31/2022
4.85%
6Q
12/31/2021
7.82%
7Q
09/30/2021
8.36%
8Q
06/30/2021
16.72%
9Q
03/31/2021
22.42%
10Q
12/31/2020
29.72%
11Q
09/30/2020
31.39%
12Q
06/30/2020
37.54%
13Q
03/31/2020
46.66%
14Q
12/31/2019
57.75%
15Q
09/30/2019
58.42%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AKEBIA THERAPEUTICS INC.
LOADING...